Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain–caspase and apoptosis signaling kinase 1–p38 mitogen-activated protein kinase activation cascades
Authors:
- Jong-Hwa ParkJPJong-Hwa Park
- Hyun-Dong PaikHPHyun-Dong Paik
- Seung-Yeol NahSNSeung-Yeol Nah
- Darrick S.H.L. KimDKDarrick S.H.L. Kim
- Ye Sun HanYHYe Sun Han
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 18 (6) , 649-657
Abstract
The molecular mechanisms of genistein-induced apoptosis of human breast cancer MCF-7 cells were investigated. Genistein showed 50% cell growth inhibition at IC50=27.5+/-0.8 micromol/l in 24 h incubation under 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay conditions. Genistein is known to express both cell growth activity at nanomolar concentrations and anti-cell growth activity at micromolar concentrations. It was found that genistein at 100 micromol/l concentration effectively induced apoptosis of MCF-7 cells in 24 h. Genistein-induced apoptosis involved activation of calpain, caspase 7 and poly(ADP ribose) polymerase. Dantrolene, an inhibitor of Ca release from the endoplasmic reticulum, inhibited genistein-induced activation of calpain and caspase 7, in addition to effectively negating genistein-induced apoptosis. MCF-7 cells treated with genistein also showed increased phosphorylation of p38 mitogen-activated protein kinase, whereas no effect was observed for extracellular signal-regulating kinase 1/2. Phosphorylation of apoptosis signaling kinase 1, an upstream regulator of p38 mitogen-activated protein kinase, was also increased by genistein treatment. Genistein-induced phosphorylation of apoptosis signaling kinase 1 and p38 mitogen-activated protein kinase was diminished by the presence of dantrolene. These results suggest that genistein-induced apoptosis in MCF-7 cells is mediated through calpain-caspase 7 and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades that involve Ca release from the endoplasmic reticulum.Keywords
This publication has 41 references indexed in Scilit:
- Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenograftsCancer, 2006
- Molecular Evidence for Increased Antitumor Activity of Gemcitabine by Genistein In vitro and In vivo Using an Orthotopic Model of Pancreatic CancerCancer Research, 2005
- Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cellsCancer Letters, 2004
- The Soy Isoflavone, Genistein, Protects Human Cortical Neuronal Cells from Oxidative StressNeuroToxicology, 2004
- Regulation of Gene Expression and Inhibition of Experimental Prostate Cancer Bone Metastasis by Dietary GenisteinNeoplasia, 2004
- Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse modelCancer Letters, 2003
- Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive AgentsThe Journal of Nutrition, 2000
- Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and βEndocrinology, 1997
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Genistein, a dietary-derived inhibitor of in vitro angiogenesis.Proceedings of the National Academy of Sciences, 1993